Skip to Content

Join the 'Stalevo' group to help and get support from people like you.

Stalevo News

Brain Disconnects Spotted in Parkinson's Patients With Visual Hallucinations

Posted 28 Sep 2017 by Drugs.com

THURSDAY, Sept. 28, 2017 – Researchers say they've discovered a possible explanation for visual hallucinations in people with Parkinson's disease. The researchers conducted brain scans on 15 patients with visual hallucinations, 40 patients without visual hallucinations, and a control group of 15 people without Parkinson's disease. In all of the Parkinson's disease patients, numerous areas of the ...

Coffee Doesn't Help Parkinson's Motor Disorders

Posted 28 Sep 2017 by Drugs.com

THURSDAY, Sept. 28, 2017 – Regular cups of coffee will not ease tremors and movement problems caused by Parkinson's disease, despite prior evidence that caffeine might help, a new clinical trial reports. Earlier short-term results from the same trial had shown caffeine improved the motor function of a small group of Parkinson patients, researchers said. But long-term results from the trial now ...

Virtual House Calls for Speedy, Effective Parkinson's Care

Posted 17 Aug 2017 by Drugs.com

THURSDAY, Aug. 17, 2017 – Parkinson's disease patients get as much benefit from seeing a neurologist via home video conference as from seeing a local doctor in person, a new study reports. The research included nearly 200 patients who received either care from their usual doctor or their usual care plus up to four video (virtual) visits with a neurologist they had not seen before. The virtual ...

Singing May Be Good Medicine for Parkinson's Patients

Posted 12 Aug 2017 by Drugs.com

FRIDAY, Aug. 11, 2017 – Singing? To benefit people with Parkinson's disease? It just may help, a researcher says. "We're not trying to make them better singers, but to help them strengthen the muscles that control swallowing and respiratory function," said Elizabeth Stegemoller, an assistant professor of kinesiology at Iowa State University. Stegemoller holds a weekly singing therapy class for ...

White Collar Workers at Higher Odds of Death From ALS, Parkinson's

Posted 13 Jul 2017 by Drugs.com

THURSDAY, July 13, 2017 – Typically, better-paying jobs and those that require higher education are thought more desirable, but a new study suggests white collar workers have a higher risk of death from two neurodegenerative diseases. The research found that richer, better-educated people with Parkinson's disease or amyotrophic lateral sclerosis (ALS, also called Lou Gehrig's disease), appear ...

150-Year-Old Drug May Shorten 'Off' Time for Parkinson's Patients

Posted 21 Apr 2017 by Drugs.com

FRIDAY, April 21, 2017 – An old standby drug seems to help patients with advanced Parkinson's disease through the difficult times when their usual medication stops working, a new trial suggests. As the movement disorder progresses, the effectiveness of the usual drug, levodopa, wears off more quickly after each dose, the researchers explained. Patients can experience so-called "off" times, which ...

FDA OKs Parkinson's Add-On Drug, Xadago (Safinamide)

Posted 22 Mar 2017 by Drugs.com

WEDNESDAY, March 22, 2017 – The U.S. Food and Drug Administration has approved a new drug for Parkinson's disease. Xadago (safinamide) pills were given the green light as an add-on treatment for people taking levodopa/carbidopa and experiencing "off" episodes. These are periods when medication effectiveness wanes, leading to a rise in symptoms such as tremor and difficulty walking. "Parkinson's ...

Is It Parkinson's or Something Else? Blood Test Might Tell

Posted 9 Feb 2017 by Drugs.com

WEDNESDAY, Feb. 8, 2017 – Measuring a particular blood protein might help doctors easily distinguish Parkinson's disease from some similar disorders, a new study suggests. The potential blood test is "not ready for prime time," Parkinson's disease experts said. But, it marks progress in the quest for an objective way to diagnose Parkinson's and similar conditions known as atypical parkinsonian ...

New Parkinson's Drug May Combat Movement Difficulties

Posted 4 Jan 2017 by Drugs.com

TUESDAY, Jan. 3, 2017 – New research suggests that people with Parkinson's disease may achieve better and more reliable motor control by taking an experimental drug called opicapone alongside the standard medication levodopa. A study of several hundred Parkinson's patients found that the drug – opicapone – boosts levodopa's ability to control the motor difficulties associated with Parkinson's, ...

Exercise May Be Real Medicine for Parkinson's Disease

Posted 22 Dec 2016 by Drugs.com

THURSDAY, Dec. 22, 2016 – Almost any exercise is good medicine for someone with Parkinson's disease, a new study confirms. Although physical activity may seem impossible for some Parkinson's patients, the new research review reaffirms what many specialists already believe: that exercise can have a long-term impact, improving gait and reducing risk of falls, in particular. "I pretty much never ...

Inhaled Version of Parkinson's Drug May Help Keep Symptoms at Bay

Posted 12 Oct 2016 by Drugs.com

WEDNESDAY, Oct. 12, 2016 – An inhaled version of the Parkinson's drug levodopa can help when patients experience symptoms between doses of the pill form of the medication, a new, small study finds. Levodopa can control the tremors, rigidity and difficulty maintaining balance and coordination associated with Parkinson's disease. However, within two years, as many as half of all patients have ...

Study Questions Use of Physical Therapy for Early Parkinson's

Posted 19 Jan 2016 by Drugs.com

TUESDAY, Jan. 19, 2016 – Physical therapy might not benefit people with mild-to-moderate Parkinson's disease, a new study suggests. Parkinson's disease is a movement disorder that interferes with the ability to do daily tasks. Typically, physical therapy is used in the later stages of the disease, but this study assessed its effectiveness in earlier stages. Researchers randomly assigned 762 ...

New Clues to Easing Side Effects From Parkinson's Drug

Posted 18 Nov 2015 by Drugs.com

WEDNESDAY, Nov. 18, 2015 – The drug levodopa is a leading treatment for Parkinson's disease, but for most patients the medication also brings debilitating side effects. Now, scientists say animal studies are pointing to a compound that might reduce those unwanted effects. "If clinical trials confirm our preliminary findings, the eventual drug developed could make a significant improvement in the ...

Parkinson's Drug Shows Promise Against Macular Degeneration

Posted 12 Nov 2015 by Drugs.com

THURSDAY, Nov. 12, 2015 – A common Parkinson's disease medication might hold potential for preventing or treating macular degeneration, the leading cause of vision loss in the elderly, new research suggests. At this stage, no one is recommending that patients take the drug, levodopa (L-dopa), to thwart eye disease. But the findings are intriguing, researchers said. "Patients taking L-dopa for ...

FDA Medwatch Alert: Entacapone: Drug Safety Communication - FDA Review Found No Increased Cardiovascular Risks

Posted 28 Oct 2015 by Drugs.com

Including Comtan (entacapone) and Stalevo (entacapone, carbidopa, and levodopa) ISSUE: An FDA safety review has found no clear evidence of an increased risk of heart attacks, stroke, or other cardiovascular events associated with the use of entacapone for the treatment of Parkinson’s disease. As a result, recommendations for using Comtan (entacapone) and Stalevo (a combination of entacapone, c ...

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Parkinson's Disease

Stalevo Patient Information at Drugs.com